Scleroderma, Vasculitis & Myositis Center


Below are selected publications of our center physicians. To view a complete list of their publications, please visit their individual pages:


WGET Research Group. Etanercept plus standard therapy for Wegener’s granulomatosis. New England Journal of Medicine. 352(4):351-61, 2005.

Spiera RF, Spiera H. Therapy for giant cell arteritis: can we do better? (Invited Editorial). Arthritis Rheum 2006;54:3071-4.

Mahr AD, Jover JA, Spiera RF, et al. Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis. Arthritis Rheum 2007;56:2789-97.

Postlethwaite AE, Wong WK, Clements P, Chatterjee S, Fessler BJ, Kang AH, Korn J, Mayes M , Merkel PA, Molitor J, Moreland L, Rothfield N, Simms RW, Smith EA, Spiera R, Steen V, Warrington K, White B, Wigley F, Furst. A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis:I. Oral type I collagen does not improve skin in all patients, but may improve skin in late-hase disease. Arthritis and Rheumatism 58 (6):1810-1822 May 2008.

Dimartino, SJ,  2008. Idiopathic Inflammatory Myopathy: Treatment options. Current Rheumatology Reports 10 (4):321-7

Dimartino, SJ,  2008. Stronger Decision Making in Myositis. Journal of Musculoskeletal Medicine.

Dimartino, SJ,  2009. Treatment of Inflammatory Myopathies. In: Kagen, L.J., editor. The Inflammatory Myopathies. New York; Humana Press

Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CGM, St. Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo L, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, and Specks U. Rituximab Versus Cyclophosphamide for the Induction of Remission In ANCA-Associated Vasculitis 2009, New England Journal of Medicine, 2010

Gordon JK, Spiera RF. Targeting tyrosine kinases: a novel therapeutic strategy for systemic sclerosis. Curr Opin Rheumatol. 2010 Nov; 22(6):690-5. PMID: 20827202

Spiera RF, Gordon JK, Mersten JN, Magro CM, Mehta M, Wildman HF, Kloiber S, Kirou KA, Lyman S, Crow MK. Imatinib Mesylate (Gleevec™) in the Treatment of Diffuse Cutaneous Systemic Sclerosis: Results of a One Year, Phase IIa, Single Arm, Open Label Clinical Trial. Accepted for Publication, Annals of Rheumatic Diseases, 2011.

Spiera RF, Westhoven R. Provisional Classification Criteria of Polymyalgia Rheumatica: moving beyond clinical intuition? (Invited Editorial) Arthritis and Rheumatism. 2012 Apr; Vol. 64, No. 4, pp 955–957


Spiera RF, Kagen LJ. Collagen vascular diseases: Polymyositis, dermatomyositis, and inclusion body myositis. In: Therapy of Systemic Rheumatic Disorders (eds, Furst D, van Riel P, Williams J), Marcell Decker, Inc,. New York, NY, 1998.

Spiera RF. Systemic Sclerosis and related disorders. In: Manual of Rheumatology and outpatient orthopedic disorders. (eds, Paget S, Gibofsky A, Pellici P), Little Brown and Co., Boston, 2000.

Spiera RF, Paget SP, Polymyalgia Rheumatica and Temporal Arteritis . In: Cecil’s Textbook of Medicine, 24th edition. 2010.

Spiera RF, Spiera, H. "Why is Sjögren’s so hard to diagnose?" The Sjögren’s Syndrome Handbook, 4th edition. (ed Wallace DJ), Oxford University Press, Inc., New York, NY, 2010

^ Back to Top
Request an Appointment